The 5-HT1A Receptor: Signaling, Desensitization, and Gene Transcription

doi:10.1016/S0893-133X(96)80055-8

Paper

DOI: 10.1016/S0893-133X(96)80055-8

The 5-HT1A Receptor: Signaling, Desensitization, and Gene Transcription

Published 1996 · P. Albert, P. Lembo, J. Storring

Neuropsychopharmacology

Q1 SJR score

136

Citations

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Highly Cited

Study Snapshot

Antianxiety and antidepressant agents enhance serotonergic neurotransmission through desensitization of 5-HT1A autoreceptors, and understanding this receptor's regulation is crucial for their therapeutic actions.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Sign up to use Study Snapshot

Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.

Create an account

Full text analysis coming soon...

References

DOI: 10.1016/s0021-9258(17)36729-7

G protein specificity in receptor-effector coupling. Analysis of the roles of G0 and Gi2 in GH4C1 pituitary cells.

Alpha 0 specifically triggers calcium channel closure, while alpha i2 mediates adenylyl cyclase inhibition in GH4C1 cells, with specificity depending on enzyme activity.

1994·157citations·Y. F. Liu et al.·The Journal of biological chemistry

The Journal of biological chemistry

DOI: 10.1016/s0022-3565(25)38604-0

Agonist-induced desensitization and loss of high-affinity binding sites of stably expressed human 5-HT1A receptors.

Agonist-induced down regulation of 5-HT1A receptors occurs after stimulation of both PKC and phospholipase A2 signaling pathways, leading to a loss of high-affinity binding sites and functional receptor coupling to adenylate cyclase.

1994·47citations·M. Harrington et al.·The Journal of pharmacology and experimental therapeutics

The Journal of pharmacology and experimental therapeutics

DOI: 10.1523/JNEUROSCI.13-12-05164.1993

Cloning and differentiation-induced expression of a murine serotonin1A receptor in a septal cell line

SN-48 septal cells differentiate into neurofilament-positive cells, expressing functional 5-HT1A receptors, providing a useful cellular model system for studying neuronal differentiation and serotonergic input sensitivity.

1993·69citations·A. Charest et al.

DOI: 10.1097/00001756-199309150-00010

Agonist-induced down-regulation of human 5-HT1A and 5-HT2 receptors in Swiss 3T3 cells.

Serotonin agonists can cause down-regulation and desensitization of human 5-HT1A and 5-HT2 receptors in Swiss 3T3 cells, with 5-HT2 receptor desensitization occurring through phosphorylation via activated PKC.

1993·29citations·F. van Huizen et al.·Neuroreport

Neuroreport

DOI:

The neuroanatomy of depression.

Depression is associated with regional brain dysfunction, affecting the frontal-temporal cortex and caudate nucleus.

1993·261citations·Jeffrey L. Cummings·The Journal of clinical psychiatry

The Journal of clinical psychiatry

Citations

DOI: 10.55959/msu2074-8132-24-3-14

The serotonin 1A receptor promoter polymorphism, rs6295, is associated with morphofunctional features

The serotonin 1A receptor promoter polymorphism, rs6295, is associated with morphofunctional features and body weight gain, potentially aiding in obesity prevention and treatment strategies.

2024·0citations·A.A. Vasileva·Moscow University Anthropology Bulletin (Vestnik Moskovskogo Universiteta Seria XXIII Antropologia)

Moscow University Anthropology Bulletin (Vestnik Moskovskogo Universiteta Seria XXIII Antropologia)

DOI: 10.4062/biomolther.2022.141

5-Hydroxytryptophan Reduces Levodopa-Induced Dyskinesia via Regulating AKT/mTOR/S6K and CREB/ΔFosB Signals in a Mouse Model of Parkinson’s Disease

5-HTP effectively reduces L-DOPA-induced dyskinesia in Parkinson's disease mice by regulating hyperactivated striatal AKT/mTOR/S6K and CREB/FosB signaling.

2023·7citations·Yujin Choi et al.·Biomolecules & Therapeutics

Biomolecules & Therapeutics

DOI: 10.1016/j.euroneuro.2022.12.003

Neurochemical mechanisms of deep brain stimulation for depression in animal models

Deep brain stimulation (DBS) in preclinical models shows antidepressant-like effects through various neurochemical changes, including changes in serotonin levels and dopamine levels.

2023·6citations·A. C. Campos et al.·European Neuropsychopharmacology

European Neuropsychopharmacology

DOI: 10.1016/j.genrep.2022.101493

Systematic identification of candidate genes associated with aggressive behavior: A neurogenetic approach

Aggressive behavior is linked to neurotransmitter genes, which could serve as early biomarkers for diagnosing and developing drug targets for therapeutics.

2022·0citations·Vajagathali Mohammed et al.·Gene Reports

Gene Reports

DOI: 10.3390/ijms222413319

Effects of a Cc2d1a/Freud-1 Knockdown in the Hippocampus on Behavior, the Serotonin System, and BDNF

Cc2d1a/Freud-1 knockdown in the hippocampus impairs memory and reduces antidepressant effects, suggesting its involvement in depressive disorders through the 5-HT1A receptor and BDNF.

2021·11citations·E. Kondaurova et al.·International Journal of Molecular Sciences

International Journal of Molecular Sciences